Cargando…
A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
BACKGROUND: Real-world evidence on factor Xa inhibitor (rivaroxaban) prescribing patterns, safety, and efficacy in patients with non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) is rare. Herein, we sought to examine the above outcomes in the largest academic center in the Kin...
Autores principales: | Alosaimi, Hind M., Alqahtani, Saeed, Balkhi, Bander, Alqahtani, Mishari, Alzamil, Faisal, Alhossan, Abdulaziz, Alqahtany, Fatmah S., Alharbi, Abdullah A., Alqahtani, Nawaf Abdullah, Albackr, Hanan, Elgohary, Ghada, Algahtani, Farjah H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466595/ https://www.ncbi.nlm.nih.gov/pubmed/36105646 http://dx.doi.org/10.7717/peerj.13974 |
Ejemplares similares
-
Hemostatic profile detailing in apparent VWD cases: A cross sectional study
por: Alqahtany, Fatmah S., et al.
Publicado: (2021) -
Factor XII deficiency in asymptomatic Saudi population: A retrospective cohort study
por: Alqahtany, Fatmah S., et al.
Publicado: (2021) -
Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series
por: AlGahtani, Farjah H, et al.
Publicado: (2023) -
The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement
por: Alghamdi, Najwa, et al.
Publicado: (2022) -
The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria
por: Algahtani, Farjah H., et al.
Publicado: (2020)